Assembly Biosciences (ASMB) Commences ABI-H0731 Phase 1 as HBV Treatment
Tweet Send to a Friend
Assembly Biosciences, Inc. (Nasdaq: ASMB) announced initiation of a Phase 1a/1b clinical trial of ABI-H0731, its initial Core protein Allosteric ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
